BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//International Health Economics Association - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:International Health Economics Association
X-ORIGINAL-URL:https://healtheconomics.org
X-WR-CALDESC:Events for International Health Economics Association
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260608T153000
DTEND;TZID=UTC:20260608T163000
DTSTAMP:20260528T153411
CREATED:20260528T170739Z
LAST-MODIFIED:20260528T171741Z
UID:335259-1780932600-1780936200@healtheconomics.org
SUMMARY:Weighing the Impacts of GLP-1s: Quasi-Experimental Evidence From Provider Adoption
DESCRIPTION:📅 Add to Calendar! |  🎥 Join Webinar on Zoom \nThe arrival of GLP-1 medications has been described as one of the most important healthcare innovations in recent years. In this webinar\, Jasmin Moshfegh (Imperial College Business School) will present large-scale quasi-experimental evidence on the real-world impacts of GLP-1 adoption. \nUsing comprehensive Veterans Health Administration data covering 1.4 million diabetic or obese veterans\, this study examines how variation in physicians’ prescribing propensities affects patient outcomes. The findings demonstrate substantial improvements in glycemic control and clinically meaningful weight loss among patients whose providers become higher propensity adopters. \nThe session will also explore the broader implications of GLP-1 adoption for healthcare utilization\, medical spending\, and health policy\, including evidence of heterogeneous impacts across patient groups. \nSpeaker: \nJasmin Moshfegh is an Assistant Professor in Economics and Public Policy at Imperial College Business School and an applied economist specializing in health economics.  \nHer research examines physician behavior\, healthcare innovation\, health inequality\, and how public policy shapes the diffusion of and access to new medical technologies. She received her PhD in Health Policy (Economics) from Stanford University in 2024 and subsequently held postdoctoral fellowships at the U.S. Department of Veterans Affairs and the National Cancer Institute at the National Institutes of Health.
URL:https://healtheconomics.org/event/weighing-the-impacts-of-glp-1s-quasi-experimental-evidence-from-provider-adoption/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
END:VCALENDAR